Zhonghong Pulin Medical Products Co., Ltd. (SZSE:300981) agreed to acquire 70% stake in Shenzhen MedRena Biotech Co., Ltd. from Zhao Guoqing, Feng Qishan, Wang Chunyan,Zhang Caihuan and Shenzhen Qihui Investment Consulting Enterprise (Limited Partnership) for CNY 58.8 million on September 27, 2023. Shenzhen MedRena Biotech Co., Ltd reported Total assets worth CNY 31.2 million and Total common equity of CNY 23.1 million in April 30, 2023. Zhonghong Pulin Medical Products' board of director's approved the transaction.
Zhonghong Pulin Medical Products Co., Ltd.
Equities
300981
CNE100004KR0
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.53 CNY | -1.26% | +3.55% | -21.79% |
1st Jan change | Capi. | |
---|---|---|
-21.79% | 683M | |
+9.48% | 27.45B | |
-28.65% | 3.11B | |
-16.08% | 2.55B | |
+19.05% | 2.48B | |
+11.11% | 2.08B | |
-4.24% | 2.03B | |
+5.56% | 1.55B | |
+1.69% | 1.29B | |
+29.73% | 1.23B |
- Stock Market
- Equities
- 300981 Stock
- News Zhonghong Pulin Medical Products Co., Ltd.
- Zhonghong Pulin Medical Products Co., Ltd. agreed to acquire 70% stake in Shenzhen MedRena Biotech Co., Ltd. from Zhao Guoqing, Feng Qishan, Wang Chunyan,Zhang Caihuan and Shenzhen Qihui Investment Consulting Enterprise (Limited Partnership) for CNY 58.8 million.